← FDA Drug Approvals (Drugs@FDA)
OPDIVO QVANTIG
BLA · Biologics License Application · Sponsor: BRISTOL-MYERS SQUIBB · Approved 2024-12-27
Drug application
- FDA Application #
BLA761381- Application type
- Biologics License Application
- Brand name
- OPDIVO QVANTIG
- Generic name
- NIVOLUMAB AND HYALURONIDASE-NVHY
- Active ingredients
- NIVOLUMAB; HYALURONIDASE-NVHY
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- BRISTOL-MYERS SQUIBB
- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- First approval
- 2024-12-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown